Philip Hasel

Philip Hasel

Auto-generated profile, based on publicly available information

Philip Hasel

Institute for Translational Neuroscience, NYU Grossman School of Medicine, New York, NY, USA; UK Dementia Research Institute at the University of Edinburgh, Edinburgh, UK; Centre for Discovery Brain Sciences, School of Biomedical Sciences, College of Medicine and Veterinary Medicine, The University of Edinburgh, Edinburgh, UK

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2021 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
PHPhilip Hasel
Philip Hasel
IRIndigo V. L. Rose
Indigo V. L. Rose
JSJessica S. Sadick
Jessica S. Sadick
RKRachel D. Kim
Rachel D. Kim
SLShane Liddelow
Shane Liddelow

6 October 2021 in Nature
Verified
Journal Article
Closed access
PDF file
KGKevin A. Guttenplan
Kevin A. Guttenplan
MWMaya K. Weigel
Maya K. Weigel
PPPriya Prakash
Priya Prakash
PWPrageeth R. Wijewardhane
Prageeth R. Wijewardhane
PHPhilip Hasel
Philip Hasel
BBBen A. Barres
Ben A. Barres

22 March 2023 in Cell Metabolism
Verified
Journal Article
Closed access
PHPhilip Hasel
Philip Hasel
WAWilliam H. Aisenberg
William H. Aisenberg
FBF. Chris Bennett
F. Chris Bennett
SLShane Liddelow
Shane Liddelow

30 November 2022 in Alzheimer's & Dementia
Verified
Journal Article
Open access
ECEmilie L. Castranio
Emilie L. Castranio
PHPhilip Hasel
Philip Hasel
JHJean‐Vianney Haure‐Mirande
Jean‐Vianney Haure‐Mirande
AJAngie V. Ramirez Jimenez
Angie V. Ramirez Jimenez
BHBradley Wade Hamilton
Bradley Wade Hamilton
MEMichelle Ehrlich
Michelle Ehrlich
Introduction: The inositol polyphosphate‐5‐phosphatase D (INPP5D) gene encodes a dual‐specificity phosphatase that can dephosphorylate both phospholipids and phosphoproteins. Single nucleotide polymorphisms in INPP5D impact risk for developing late onset sporadic Alzheimer's disease (LOAD).Methods: To assess the consequences of inducible Inpp5d knockdown in microglia of APPKM670/671NL/PSEN1Δexon9 (PSAPP) mice, we injected 3‐month‐old Inpp5dfl/fl/Cx3cr1CreER/+ and PSAPP/Inpp5dfl/fl/Cx3cr1CreER/+ mice with either tamoxifen (TAM) or corn oil (CO) to induce recombination.Results: At age 6 months, we found that the percent area of 6E10+ deposits and plaque‐associated microglia in Inpp5d knockdown mice were increased compared to controls. Spatial transcriptomics identified a plaque‐specific expression profile that was extensively altered by Inpp5d knockdown.Discussion: These results demonstrate that conditional Inpp5d downregulation in the PSAPP mouse increases plaque burden and recruitment of microglia to plaques. Spatial transcriptomics highlighted an extended gene expression signature associated with plaques and identified CST7 (cystatin F) as a novel marker of plaques.Highlights: Inpp5d knockdown increases plaque burden and plaque‐associated microglia number. Spatial transcriptomics identifies an expanded plaque‐specific gene expression profile. Plaque‐induced gene expression is altered by Inpp5d knockdown in microglia. Our plaque‐associated gene signature overlaps with human Alzheimer's disease gene networks.

20 February 2025 in Cell Reports
Verified
Journal Article
Open access
PHPhilip Hasel
Philip Hasel
MCMelissa L. Cooper
Melissa L. Cooper
AMAnne E. Marchildon
Anne E. Marchildon
URUriel Rufen-Blanchette
Uriel Rufen-Blanchette
RKRachel D. Kim
Rachel D. Kim
SLShane Liddelow
Shane Liddelow
Astrocytes are a highly abundant glial cell type and perform critical homeostatic functions in the central nervous system. Like neurons, astrocytes have many discrete heterogeneous subtypes. The subtype identity and functions are, at least in part, associated with their anatomical location and can be highly restricted to strategically important anatomical domains. Here, we report that astrocytes forming the glia limitans superficialis, the outermost border of the brain and spinal cord, are a highly specialized astrocyte subtype and can be identified by a single marker: myocilin (Myoc). We show that glia limitans superficialis astrocytes cover the entire brain and spinal cord surface, exhibit an atypical morphology, and are evolutionarily conserved from zebrafish, rodents, and non-human primates to humans. Identification of this highly specialized astrocyte subtype will advance our understanding of CNS homeostasis and potentially be targeted for therapeutic intervention to combat peripheral inflammatory effects on the CNS.

23 September 2024 in Glia
Verified
Journal Article
Open access
MOMichael R. O'DEa
Michael R. O'DEa
PHPhilip Hasel
Philip Hasel
Astrocytes are a highly abundant cell type in the brain and spinal cord. Like neurons, astrocytes can be molecularly and functionally distinct to fulfill specialized roles. Recent technical advances in sequencing‐based single cell assays have driven an explosion of omics data characterizing astrocytes in the healthy, aged, injured, and diseased central nervous system. In this review, we will discuss recent studies which have furthered our understanding of astrocyte biology and heterogeneity, as well as discuss the limitations and challenges of sequencing‐based single cell and spatial genomics methods and their potential future utility.